000 01634 a2200469 4500
005 20250516074813.0
264 0 _c20120723
008 201207s 0 0 eng d
022 _a1791-2431
024 7 _a10.3892/or.2012.1666
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMauceri, Helena J
245 0 0 _aEverolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer.
_h[electronic resource]
260 _bOncology reports
_cMay 2012
300 _a1625-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aCombined Modality Therapy
650 0 4 _aEverolimus
650 0 4 _aFemale
650 0 4 _aGene Expression
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aRadiation, Ionizing
650 0 4 _aRadiation-Sensitizing Agents
_xpharmacology
650 0 4 _aRibosomal Protein S6 Kinases, 70-kDa
_xmetabolism
650 0 4 _aSirolimus
_xanalogs & derivatives
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aSutton, Harold G
700 1 _aDarga, Thomas E
700 1 _aKocherginsky, Masha
700 1 _aKochanski, Joel
700 1 _aWeichselbaum, Ralph R
700 1 _aVokes, Everett E
773 0 _tOncology reports
_gvol. 27
_gno. 5
_gp. 1625-9
856 4 0 _uhttps://doi.org/10.3892/or.2012.1666
_zAvailable from publisher's website
999 _c21507178
_d21507178